Brickell Biotech, Inc. Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Brickell Biotech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Brickell Biotech, Inc. for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | P | 0.84 | 6,000 | 5,039 | 6,000 | 0 to 6 K |
| Sep 21 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | P | 0.83 | 16,526 | 13,713 | 75,883 | 59.4 K to 75.9 K (+27.84 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Grant | A | 0.81 | 10,493 | 8,499 | 23,542 | 13 K to 23.5 K (+80.41 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Gift | G | 0.00 | 19,642 | 0 | 980,030 | 960.4 K to 980 K (+2.05 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | P | 0.80 | 14,645 | 11,758 | 50,810 | 36.2 K to 50.8 K (+40.49 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | P | 0.81 | 15,355 | 12,416 | 36,165 | 20.8 K to 36.2 K (+73.79 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Grant | A | 0.81 | 13,580 | 11,000 | 20,810 | 7.2 K to 20.8 K (+187.83 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Gift | G | 0.00 | 19,642 | 0 | 7,230 | 26.9 K to 7.2 K (-73.09 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Grant | A | 0.81 | 11,934 | 9,667 | 24,729 | 12.8 K to 24.7 K (+93.27 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Grant | A | 0.81 | 15,226 | 12,333 | 205,849 | 190.6 K to 205.8 K (+7.99 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | A | 0.80 | 350,000 | 280,000 | 350,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | A | 0.80 | 150,000 | 120,000 | 150,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | A | 0.80 | 400,000 | 320,000 | 400,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | A | 0.80 | 450,000 | 360,000 | 450,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Brown Robert Busard | Chief Executive Off ... | Option Exercise | A | 0.80 | 1,000,000 | 800,000 | 1,000,000 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 788 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 788 | 0 | 960,388 | 959.6 K to 960.4 K (+0.08 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 609 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 0.94 | 6,375 | 5,993 | 13,049 | 19.4 K to 13 K (-32.82 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 0.94 | 256 | 241 | 19,424 | 19.7 K to 19.4 K (-1.30 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 609 | 0 | 19,680 | 19.1 K to 19.7 K (+3.19 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 8,631 | 8,113 | 12,795 | 21.4 K to 12.8 K (-40.28 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 346 | 325 | 21,426 | 21.8 K to 21.4 K (-1.59 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 21,772 | 21.1 K to 21.8 K (+3.28 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 883 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 0.94 | 7,048 | 6,625 | 190,623 | 197.7 K to 190.6 K (-3.57 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 0.94 | 283 | 266 | 197,671 | 198 K to 197.7 K (-0.14 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 883 | 0 | 197,954 | 197.1 K to 198 K (+0.45 %) |